NERI, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.718
EU - Europa 6.167
AS - Asia 3.598
SA - Sud America 426
AF - Africa 100
OC - Oceania 98
Totale 19.107
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.631
RU - Federazione Russa 2.211
IT - Italia 1.139
SG - Singapore 1.058
CN - Cina 788
HK - Hong Kong 593
IE - Irlanda 472
UA - Ucraina 446
VN - Vietnam 442
PL - Polonia 425
SE - Svezia 412
DE - Germania 373
BR - Brasile 345
KR - Corea 295
FI - Finlandia 203
FR - Francia 195
GB - Regno Unito 137
IN - India 125
AU - Australia 96
CH - Svizzera 79
JO - Giordania 62
CA - Canada 53
TR - Turchia 36
BD - Bangladesh 31
JP - Giappone 31
ID - Indonesia 28
AR - Argentina 25
NL - Olanda 24
SC - Seychelles 23
EC - Ecuador 22
IQ - Iraq 22
CI - Costa d'Avorio 18
NG - Nigeria 17
MX - Messico 15
ES - Italia 13
BE - Belgio 12
PK - Pakistan 11
PH - Filippine 10
PY - Paraguay 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
MA - Marocco 9
ZA - Sudafrica 9
VE - Venezuela 8
TN - Tunisia 7
UZ - Uzbekistan 7
CR - Costa Rica 6
OM - Oman 6
CO - Colombia 5
KE - Kenya 5
KG - Kirghizistan 5
LT - Lituania 5
SA - Arabia Saudita 5
EG - Egitto 4
IR - Iran 4
KZ - Kazakistan 4
TW - Taiwan 4
CL - Cile 3
CZ - Repubblica Ceca 3
PE - Perù 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
AO - Angola 2
AT - Austria 2
BO - Bolivia 2
CD - Congo 2
DK - Danimarca 2
HN - Honduras 2
JM - Giamaica 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PR - Porto Rico 1
RS - Serbia 1
SV - El Salvador 1
Totale 19.105
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.476
Jacksonville 687
Singapore 676
Ashburn 654
Chandler 586
Dublin 471
Hong Kong 469
Warsaw 420
Fairfield 408
San Jose 300
Seoul 292
Milan 271
Cambridge 193
Beijing 185
Wilmington 182
Woodbridge 177
Buffalo 167
Seattle 161
Boardman 150
Houston 146
Los Angeles 140
Princeton 139
Ho Chi Minh City 135
Lauterbourg 122
Hefei 112
Boston 110
Hanoi 102
The Dalles 102
Ann Arbor 98
Mumbai 95
Rome 95
Melbourne 94
Munich 94
Bern 77
New York 73
Medford 66
Florence 60
Shanghai 57
Moscow 48
Altamura 45
Lawrence 44
Paris 41
Helsinki 39
Naples 37
Kent 35
Turku 34
Tokyo 30
Council Bluffs 28
Dallas 28
San Diego 28
Turin 28
São Paulo 27
Auburn Hills 26
Figino 26
Norwalk 24
Verona 24
Orem 23
Frankfurt Am Main 22
Haiphong 22
Izmir 22
Palermo 22
Toronto 22
Frankfurt am Main 20
Hillsboro 20
Abidjan 18
Da Nang 18
Andover 17
Jakarta 17
Yubileyny 17
Brooklyn 16
Abuja 15
Bologna 15
Montreal 15
Portsmouth 15
San Francisco 15
Bari 13
London 11
Rio de Janeiro 11
Venice 11
Brussels 10
Clifton 10
Denver 10
Guayaquil 10
Manchester 10
Phoenix 10
Poplar 10
Shenzhen 10
Stockholm 10
Baghdad 9
Belo Horizonte 9
Biên Hòa 9
Brasília 9
Dearborn 9
Guangzhou 9
Redondo Beach 9
Baku 8
Brescia 8
Cagliari 8
Can Tho 8
Quito 8
Totale 12.024
Salva come PNG Salva come JPEG
Nome #
GEMCITABINE PLUS IRINOTECAN AS FIRST-LINE WEEKLY THERAPY IN LOCALLY ADVANCED AND/OR METASTATIC PANCREATIC CANCER 349
Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: A phase II study 347
SURVIVAL AND PROGNOSTIC FACTORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED BY PERCUTANEOUS ETHANOL INJECTION: A 10-YEAR EXPERIENCE. 225
Biweekly sunitinib regimen reduces toxicity and retains efficacy in metastatic renal cell carcinoma: A single-center experience with 31 patiens 223
ROLE OF CONVENTIONAL TREATMENTS ON CIRCULATING AND MONOCYTE-DERIVED DENDRITIC CELLS IN COLORECTAL CANCER 211
Treatment of locally advanced hepatocellular carcinoma by hepatic intra-artery chemotherapy: a pilot study. 211
Long-term survival in metastatic melanoma patients treated with sequential biochemotherapy: report of a Phase II study. 210
Weekly gemcitabine plus Epirubicin as effective chemotherapy for advanced pancreatic cancer: a multicenter phase II study 191
Variazioni circadiane della capacità totale di ferro fissazione di un gruppo di soggetti sani 189
Asymptomatic synchronous brain metastasis of low rectal cancer; cancer report and review 187
P53 and DPC4 alterations in the bile of patients with pancreatic carcinoma 184
Effects of Melatonin administration on cytochine production in patients with advanced solid tumors 178
Antiproliferative activity of melatonin by transcriptional inhibition of cyclin D1 expression: a molecular basis for melatonin-induced oncostatic effects. 178
An uncommon clinical presentation of retroperitoneal non-Hodgkin lymphoma successfully treated with chemotherapy: a case report 176
Phase II trial of weekly intravenous gemcitabine administration with interferon and interleukin-2 immunotherapy for metastatic renal cell cancer. 173
Weekly administration of docetaxel and epirubicin as first-line treatment for hormone refractory prostate cancer 173
Variazioni circadiane delle proteine sieriche in soggetti apparentemente sani 172
Beta2-microglobulina, marker tumorale nel mieloma multiplo 171
"ADJUVANT CHEMOTHERAPY AFTER GASTRIC RESECTION IN NODE POSITIVE CANCER PATIENS: A MULTICENTRIC RANDOMIZED STUDY" 171
"DIFFERENCES BETWEEN CARNITINE DERIVATIVES AND COENZYME Q10 IN PREVENTING IN VITRO, DOXORUBICIN RELATED CARDIAC DAMAGES" 170
Raltitrexed plus oxaliplatin as first-line chemotherapy in metastatic colorectal carcinoma: a multicentric phase II trial. 170
"ANTHRACYCLINE CARDIOTOXICITY: IN VIVO AND ON VITRO EFFECTS" 169
Creatine Kinase isoenzyme BB : a lung cancer associated marker 167
Melatonin's growth-inhibitory effect on hepatoma AH 130 in the rat. 167
Aspetti circadiani del metabolismo del ferro 165
Gemcitabine plus docetaxel as first-line biweekly therapy in locally advanced and/or metastatic urothelial carcinoma: a phase II study 165
D2 resection for gastric cancer in aged patient 165
Behaviour of atrial natriuretic factor in anthracycline-related cardiac toxicity 164
CHRONOBIOLOGICAL ASPECTS OF PHOSPHOHEXOSE-ISOMERASE IN MONITORING MULTIPLE MYELOMA 164
Melatonin as Biological Response Modifier in Cancer Patients 163
"OSTEOCALCIN AS A BIOLOGICAL MARKER IN THE MANAGEMENT OF BREAST CANCER BONE METASTASES" 162
Modulation by Lonidamine of the antiproliferative activity of Adriamycin on Yoshida hepatoma of the rat 162
Circadian rhythm in several components of the complement cascade in healthy women 162
Cyclophosphamide, epirubicin and carboplatin as treatment for advanced carcinoma of the bladder: a phase II study 161
Assessment of Phosphohexose-isomerase, Beta2-microgubulin and Ferritin in lung cancer 160
"CONVENTIONAL VS HIGH DOSE EPIDOXORUBICIN AS SINGLE AGENT IN ADVANCED BREAST CANCER" 160
THE MULTIPLE DRUG RESISTANCE PHENOTYPE AND ITS CONSEQUENCES FOE CELL BIOLOGY OF CANCER CELLS 159
VENTRICULAR LATE POTENZIALS IN THE ASSESSMENT OF MITOXANTRONE CARDIOTOXICITY 158
Gemcitabine plus irinotecan as first line weekly therapy in locally advanced and/or metastatic pancreatic cancer 158
Echocardiographic assessment of anthracycline cardiotoxicity during different therapeutic regimens 156
Adjuvant chemotherapy after gastric resection in node positive cancer patients: a multicentric randomized study 156
Postoperative chemotherapy in resected gastric cancer: results of a single center experience. 155
FERRITIN AS CHRONOBIOLOGICAL MARKER IN IMMUNOPROLIFERATIVE DISEASE 154
Intra-arterial chemotherapy with 5-fluorouracil and 5-methyltetrahydrofolate in the treatment of unresectable liver metastases from colorectal cancer 154
Studio prospettico sul carcinoma del colon e angiogenesi: risultati preliminari 151
Bioperiodicità dell'escrezione urinaria di catene leggere nel mieloma : un potenziale marker ritmico 149
Dose-finding study of gemcitabine and epirubicin in patients with advanced pancreatic cancer. 148
The role of a new monoclonal antibody assay in the detection of recurrent breast cancer 148
Weekly paclitaxel and epirubicin in the treatment of symptomatic hormone-refractory advanced prostate carcinoma:a phase II trial 148
Effetto cronofarmacologico della calcitonina porcina nella malattia ossea di Paget 147
An uncommon clinical onset of colonic cancer: peripheral paraneoplastic neuropathy 147
Complete androgen blockade as treatment for advanted prostate cancer: clinical response and side-effects 147
"CIRCADIAN VARIATIONS OF PHOSPHOHEXOSE-ISOMERASE IN MULTIPLE MYELOMA" 147
Oncologia Clinica 146
Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up. 146
Tecnica di laboratorio e bioritmi : studio circadiano di alcuni parametri emocitometrici 145
Tyrosinase mRNA levels in the blood ofuveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression. 144
"Circadian study of immunoreactive prolactin in patiens with cirrhosis of the liver" 143
Aspetti cronobiologici del metabolismo proteico nella cirrosi epatica 143
The role of CA 15-3 and MCA Monoclonal Antibody Assay in the detection of Primary and Recurrent Breast cancer 140
Adriamycin and 4-Epi-Doxorubicin : Effects on endogenous respiration in rat heart slices 140
MICROARRAYS-BASED STUDY IN PANCREATIC CARCINOMA 140
Results of leucovorin and doxifluridine oral regimen in the treatment of metastatic colorectal cancer 139
Hemopsy reveals circadian mesor decrease, amplitude increase and acrophase advance for the third component of complement in fibrocystic mastophaty 139
CLINICAL UTILITY OF COMBINED USE OF PLURIME TUMOR MARKERS IN HUMAN BREAST CANCER 138
Esiste un cronorischio nell'artero-sclerosi? 137
INHIBITION OF ENDOGENOUS RESPIRATION AS A MEASURE OF MITOXANTRONE CARDIAC TOXICITY 136
Preliminary study on behaviour of atrial natriuretic factor in anthracycline-related cardiac toxicity 136
Weekly epidoxorubicin therapy in hormone-refractory metastatic prostate cancer. 136
Effects of melatonin administration in patients with advanced solid tumors 135
Circadian variation of serum prolactin and THS in women with health or with mammary carcinoma, fibroadenoma or fibrocystic mastopathy 135
Phosphohexose-isomerase as tumor marker in hepatoma bearing rats 134
Effect of antracyclines and mitoxantrone on oxygen uptake and ATP intracellular concentration in rat heart slices 133
Clinical aspects of doxorubicin and epirubicin cardiotoxicity in cancerous patiens 132
FEC VERSUS EM WITH OR WITHOUT LONIDAMINE AS FIRST-LINE TREATMENT FOR ADVANCED BREAST CANCER: A MULTICENTRIC RANDOMIZED STUDY. FINAL RESULTS 130
Epirubicin high dose in advanced breast cancer: preliminary clinical data 129
Control of nephrotoxicity by hydration-diuresis, and of emesis by alizapride in patiens with bladder cancer 129
RECOMBINANT HUMAN ERYTHROPOIETIN IN THE TREATMENT OF CHEMOTHERAPY-INDUCED ANEMIA AND PREVENTION OF TRANSFUSION REQUIREMENT ASSOCIATED WITH SOLID TUMORS: A RANDOMIZED, CONTROLLED STUDY. 125
STUDIO CON AUTOFLUORESCANZA SU LINFONODI METASTATICI NEI TUMORI DEL TRATTO GASTROENTERICO 125
The efficacy and tolerability of a sunitinib 3-week administration schedule in metastatic renal cell carcinoma patients: report of three Cases 125
Clinical utility of the combined use of plurime tumor markers in human breast cancer 125
Adjuvant chemotherapy after surgery for gastric cancer 125
Biweekly sunitinib regimen reduces toxicity and retains efficacy in metastatic renal cell carcinoma: a single-center experience with 31 patients 124
Variazioni circadiane della prolattina sierica in un gruppo di soggetti apparentemente sani 124
Reduction of cardiac toxicity of anthhracyclines by L-Carnitine: preliminary overview of clinical data 123
Doxorubicin and epirubicin cardiotoxicity: experimental and clinical aspects 123
Studio Chronobiologico della bilirubinemia in pazienti con cirrosi epatica 121
CIRCULATING IMMUNE COMPLEXES AS TUMOR MARKERS IN THE FOLLOW UP BREAST CANCER 120
Free-radical production and nucleotide loss in anthracycline-induced cardiac damage 120
Long-term biochemotherapy with cytokines and gencitabine in metastatic renal cell cancer: a phase II study 120
In vitro evaluation of organ metabolic toxicity of a new synthetic tripeptide versus L-phenylalanine-mustard 119
The role of Megestrol Acetate in neoplastic anorexia and cachexia 119
Doxorubicin plus Lonidamine: in vivo metabolic effects on the rat hearth 119
Bio-markers in the detection of myeloproliferactive diseases : a combined study on Phosphohexose isomerase Beta2-microglobulin ad Ferritin 119
Detection of circulating Immune Complex in Gynecological Malignancies 119
"COMBINATION CHEMOTHERAPY WITH EPIRUBICIN AND MYTOMICIN C AS FIRST-LINE TREATMENT IN ADVANCED BREAST CANCER" 119
Controlli di qualità di metodiche radioimmunologiche : implicazioni cronobiologiche 118
Cyclophosphamide, epidoxorubicin and Carboplatin as treatment for advanced-carcinoma of the bladder - a phase-ii study. 118
Treatment of unresecable liver metastases from colorectal carcinoma with hepatic arterial and systemic chemotherapy 118
La prevalenza dell'anemia nei pazienti oncologici sottoposti a chemioterapia: Indagine Italiana a livello nazionale 118
Totale 15.388
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.832
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.832
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021121 0 0 0 0 0 0 0 0 0 0 0 121
2021/2022799 9 123 13 70 22 18 18 44 26 13 225 218
2022/20232.149 219 224 111 150 230 409 272 137 240 11 51 95
2023/2024821 43 95 150 48 35 77 35 214 9 15 44 56
2024/20256.263 182 647 401 955 2.057 968 61 204 309 125 208 146
2025/20265.446 705 818 336 284 670 135 726 234 304 305 122 807
Totale 19.176